Índice de Salud Prostática (phi) / Prostate Health Index (phi)
Med. lab
;
26(1): 91-98, 2022. ilus, Grafs, Tabs
Article
in Spanish
| LILACS
| ID: biblio-1370967
RESUMEN
El antígeno específico de próstata (PSA, del inglés, Prostate Specific Antigen) es una glicoproteína producida por la próstata, y es el marcador tumoral de mayor uso. Sin embargo, su baja especificidad para diferenciar entre cáncer de próstata y otras alteraciones no malignas, como la hipertrofia benigna de la próstata (HBP) y la prostatitis aguda, limitan su utilidad diagnóstica
ABSTRACT
Prostate Specific Antigen (PSA) is a glycoprotein produced by the prostate and is the most widely used tumor marker. However, its low specificity to differentiate between prostate cancer and other non-malignant conditions, such as benign prostate hypertrophy (BPH) and acute prostatitis, limits its diagnostic utility
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Prostate-Specific Antigen
Type of study:
Practice guideline
Language:
Spanish
Journal:
Med. lab
Journal subject:
Bacteriology
/
Medicine
Year:
2022
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Editora Médica Colombiana/CO
/
Laboratorio Clínico Hematológico S.A/CO
Similar
MEDLINE
...
LILACS
LIS